View in EDS

Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation.

Saved in:

Bibliographic Details
Title:	Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation.
Authors:	Bartlett JA; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA. jeremy.a.bartlett@pfizer.com., Culver N; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Santangelo M; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Prpich A; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Long E; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Sagawa K; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Shanker R; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Xu H; Global Research and Development, Clinical Pharmacology, Pfizer Inc., San Diego, CA, USA., Wilner K; Global Research and Development, Clinical, Pfizer Inc., San Diego, CA, USA.
Source:	Pharmaceutical medicine [Pharmaceut Med] 2026 May; Vol. 40 (3), pp. 193-207. Date of Electronic Publication: 2026 Apr 01.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101471195 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1993 (Electronic) Linking ISSN: 11782595 NLM ISO Abbreviation: Pharmaceut Med Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1179-1993
DOI:	10.1007/s40290-026-00604-2